
Ceribell Inc (CBLL) Stock Forecast & Price Target
Ceribell Inc (CBLL) Analyst Ratings
Bulls say
CeriBell is a medical technology company with a strong focus on neurological conditions. The company's proprietary Ceribell System utilizes advanced AI-powered algorithms to enable rapid diagnosis and continuous monitoring of patients with neurological conditions. The company has already gained significant commercial traction and is actively investing in its salesforce and pipeline to drive near-term and long-term growth. With a healthy financial profile and a strong focus on innovation, CeriBell is well-positioned for success in the growing medical technology market.
Bears say
CeriBell is a medical technology company with a negative outlook. Despite receiving FDA approval to expand its on-label indication to pediatrics and neonates, its profitability may be affected by its high expenses and ongoing IP litigation costs. Additionally, there is uncertainty regarding the company's timeline and revenue level to reach cash-flow breakeven. While there may be potential for growth with its new offerings and initiatives, the company faces competition in the market and potential challenges with tariffs on imports from China.
This aggregate rating is based on analysts' research of Ceribell Inc and is not a guaranteed prediction by Public.com or investment advice.
Ceribell Inc (CBLL) Analyst Forecast & Price Prediction
Start investing in Ceribell Inc (CBLL)
Order type
Buy in
Order amount
Est. shares
0 shares